收藏切换
Research progress on the molecular mechanisms of sorafenib-induced cardiotoxicity and preventive strategies
收藏切换
PDF
Zhi-wei LIU1, Zi-ru DAI2, Xin-zhong LI2, Shuang TANG2, Dong-sheng SUN1, Min Wang2, Hang XIAO2, Wen-lan LI1, Gui-bo SUN3
Chinese Journal of Clinical Pharmacology | 2025, 41(22) : 3255 - 3261
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(22): 3255-3261
Review
Research progress on the molecular mechanisms of sorafenib-induced cardiotoxicity and preventive strategies
Full
Zhi-wei LIU1, Zi-ru DAI2, Xin-zhong LI2, Shuang TANG2, Dong-sheng SUN1, Min Wang2, Hang XIAO2, Wen-lan LI1, Gui-bo SUN3
Affiliations
  • 1.School of Pharmacy, Harbin University of Commerce, Harbin 150076, Heilongjiang Province, China
  • 2.Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China
  • 3.Hainan Branch, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Haikou 570311, Hainan Province, China
Published: 2025-11-28 doi: 10.13699/j.cnki.1001-6821.2025.22.016
Outline
收藏切换

As a multi-target tyrosine kinase inhibitor, sorafenib is the core therapeutic drug for advanced hepatocellular carcinoma, renal cell carcinoma and differentiated thyroid cancer. However, its cardiotoxicity significantly limits clinical application, mainly manifests in hypertension, myocardial ischemia, heart failure, arrhythmia, and thrombosis/hemorrhage events, which seriously affect the patient’s prognosis. This paper deeply explores the molecular mechanisms of sorafenib inducing cardiotoxicity, including key pathways such as oxidative stress and mitochondrial dysfunction, autophagy imbalance, ribonucleic acid binding motif protein 20 (RBM20) mediated gene splicing abnormalities, calcium homeostasis imbalance and myocardial electrophysiological abnormalities; at the same time, a systematic summary of clinical prevention and treatment strategies, covering monitoring and intervention measures for adverse reactions such as hypertension and heart failure, as well as research progress in experimental therapeutic drugs.

sorafenib  /  cardiotoxicity  /  oxidative stress  /  RNA-binding motif protein 20  /  calcium homeostasis imbalance
Zhi-wei LIU, Zi-ru DAI, Xin-zhong LI, Shuang TANG, Dong-sheng SUN, Min Wang, Hang XIAO, Wen-lan LI, Gui-bo SUN. Research progress on the molecular mechanisms of sorafenib-induced cardiotoxicity and preventive strategies[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (22) : 3255 -3261 . DOI: 10.13699/j.cnki.1001-6821.2025.22.016
Year 2025 volume 41 Issue 22
PDF
170
35
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.22.016
  • Receive Date:2025-08-05
  • Online Date:2026-08-05
  • Published:2025-11-28
Article Data
Affiliations
History
  • Received:2025-08-05
Funding
Affiliations
    1.School of Pharmacy, Harbin University of Commerce, Harbin 150076, Heilongjiang Province, China
    2.Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China
    3.Hainan Branch, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Haikou 570311, Hainan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.22.016
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT